Packaging Related Topics 
STAT
DECEMBER 11, 2023
WASHINGTON — The House passed a relatively major health care package late Monday, an end-of-year victory after the same policies had to be yanked from consideration in September because they lacked bipartisan support. 19 deadline to fund the government and extend funding for certain health programs in particular.
STAT
NOVEMBER 2, 2023
The package crafted by Senate Finance Chair Ron Wyden (D-Ore.) The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July. and Mike Crapo (R-Idaho) is slated to be marked up on Nov.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 27, 2023
The legislation would package together versions of health care policies that the committee has been working on for some time. WASHINGTON — The Senate Finance Committee plans to vote Nov. Read the rest…
STAT
MARCH 3, 2024
That year-end deadline lines up with the expiration of telehealth pay policies , setting the stage for a large health legislative package and giving Congress another shot at aligning hospital and doctor office payments and reforming the business practices of drug middlemen.
STAT
JUNE 20, 2023
Much of the Americas already has so-called front of package labels — small symbols printed on packaged foods that alert consumers when a food is high in certain unhealthy nutrients like sodium or saturated fat. Now, the Food and Drug Administration is embarking on a major study to test front of package labels here in the U.S.,
STAT
JULY 17, 2023
The House Energy & Commerce Committee already introduced, held multiple hearings on, and unanimously passed out of committee a package of legislation including transparency requirements for hospitals and pharmacy benefit managers and a so-called “site-neutral” pay policy for drugs administered in doctors’ offices.
STAT
MAY 25, 2023
government on Thursday unveiled an $800 million package to bolster the life sciences, highlighting officials’ efforts to grow the industry even as biopharma companies have raised alarms about policies they say are deterring them from investing further in the country. LONDON — The U.K.
Expert insights. Personalized for you.
363 
Let's personalize your content